Safety evaluation of a recombinant plasmin derivative lacking kringles 2-5 and rt-PA in a rat model of transient ischemic stroke
Authors:
- R Christian CrumrineRCR Christian Crumrine
- Victor J MarderVMVictor J Marder
- G McLeod TaylorGTG McLeod Taylor
- Joseph C LaMannaJLJoseph C LaManna
- Constantinos P TsipisCTConstantinos P Tsipis
- Valery NovokhatnyVNValery Novokhatny
- Philip ScuderiPSPhilip Scuderi
- Stephen R PettewaySPStephen R Petteway
- Vikram AroraVAVikram Arora
Open Access
- 16 May 2012
- journal article
- Published by Springer Nature in Experimental & Translational Stroke Medicine
- Vol. 4 (1) , 10
Abstract
Tissue type plasminogen activator is the only approved thrombolytic agent for the treatment of ischemic stroke. However, it carries the disadvantage of a 10-fold increase in symptomatic and asymptomatic intracranial hemorrhage. A safer thrombolytic agent may improve patient prognosis and increase patient participation in thrombolytic treatment. A novel direct-acting thrombolytic agent, Δ(K2-K5) plasmin, promising an improved safety profile was examined for safety in the snare ligature model of stroke in the rat.Keywords
This publication has 47 references indexed in Scilit:
- Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion modelExperimental & Translational Stroke Medicine, 2011
- Thrombolysis With PlasminStroke, 2010
- Different Strokes for Different Folks: The Rich Diversity of Animal Models of Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2010
- Human Recombinant Tissue-Plasminogen Activator (Alteplase): Why Not Use the ‘Human’ Dose for Stroke Studies in Rats?Journal of Cerebral Blood Flow & Metabolism, 2010
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical RecommendationsStroke, 2009
- Long-term stability of recombinant tissue plasminogen activator at -80 CBMC Research Notes, 2009
- Involvement of Thrombolysis in Recombinant Tissue Plasminogen Activator-Induced Cerebral Hemorrhages and Effect on Infarct Volume and Postischemic Endothelial FunctionStroke, 2003
- Impairment of metabolic recovery with increasing periods of middle cerebral artery occlusion in rats.Stroke, 1990
- The evolution of focal ischemic damage: A metabolic analysisMetabolic Brain Disease, 1990
- Effect of Lactacidosis on Pyridine Nucleotide Stability During Ischemia in Mouse BrainJournal of Neurochemistry, 1987